EP2431741
Methods for determining active ingredients in pro-drug PEG protein conjugates with releasable PEG reagents (in vitro de-pegylation)
:
EP einkaleyfi: Þýðing ekki lögð inn:
20.10.2009:
21.8.2013:
11009919.9
:
19.10.2029
:
Methods for determining active ingredients in pro-drug PEG protein conjugates with releasable PEG reagents (in vitro de-pegylation)
20.10.2009
21.8.2013
:
Baxter International Inc:
One Baxter Parkway, 60015, Deerfield, IL, US
:
Baxter Healthcare SA:
Thurgauerstrasse 130, 8152, Glattpark (Opfikon), CH
:
Nektar Therapeutics:
455 Mission Bay Boulevard South, Suite 100, 94158, San Francisco, CA, US
:
Varadi, Katalin:
Vienna, AT
:
Schrenk, Gerald:
Vienna, AT
:
Rottensteiner, Hanspeter:
Vienna, AT
:
Turecek, Peter:
Klosterneuburg, AT
:
Weber, Alfred:
Vienna, AT
:
Anderle, Heinz:
Klosterneuburg, AT
:
Culbertson, Sean M.:
Gurley AL, US
:
Fang, Zhihao:
MadisonAL, US
:
Zappe, Harold:
Harvest, US
:
Zhang, Ping:
Millbrae CA, US
:
Bossard, Mary J.:
Madison AL, US
:
10725708 P:
21.10.2008:
US
:
24263409 P:
15.9.2009:
US
:
G01N 33/542, G01N 33/58, G01N 33/68, G01N 33/86